Clinical Trials on 肿瘤,结直肠 in Colombia
总计4644个结果
-
University Health Network, TorontoBritish Columbia Cancer Agency; Terry Fox Research Institute主动,不招人
-
Instituto Nacional de Cancerologia, Columbia终止
-
National Cancer Institute (NCI)终止
-
British Columbia Cancer Agency完全的
-
University of British ColumbiaLotte & John Hecht Memorial Foundation完全的
-
Instituto Nacional de Cancerologia, ColumbiaUniversidad Nacional de Colombia未知
-
Medstar Health Research InstituteNational Committee for Quality Assurance尚未招聘
-
Georgetown UniversityNational Cancer Institute (NCI); Temple University完全的
-
Saint John's Cancer InstituteNational Cancer Institute (NCI)主动,不招人
-
Kelowna Gastroenterology AssociatesVeteran Affairs Sepulveda Ambulatory Care Cente完全的
-
Novartis Pharmaceuticals完全的
-
Georgetown UniversityNational Cancer Institute (NCI); Mayo Clinic; Emory University; Indiana University; Thomas Jefferson... 和其他合作者终止
-
Bristol-Myers Squibb完全的
-
Canadian Cancer Trials GroupOncolytics Biotech完全的
-
Georgetown UniversityGlaxoSmithKline完全的
-
NuCana plc主动,不招人
-
University of British Columbia完全的
-
Hospital Universitario San IgnacioPontificia Universidad Javeriana尚未招聘急性髓性白血病 | 结直肠肿瘤 | 胰腺肿瘤 | 急性白血病 | 急性髓性白血病,复发 | 肿瘤,胃 | 恶性胃肿瘤 | 急性白血病复发 | 急性白血病淋巴哥伦比亚
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)主动,不招人转移性结直肠腺癌 | IV 期结直肠癌 AJCC v8 | IVA 期结直肠癌 AJCC v8 | IVB 期结直肠癌 AJCC v8 | IVC 期结直肠癌 AJCC v8 | III 期结直肠癌 AJCC v8 | IIIA 期结直肠癌 AJCC v8 | IIIB 期结直肠癌 AJCC v8 | IIIC 期结直肠癌 AJCC v8 | BRAF V600E 负极 | KRAS基因突变阴性 | 局部晚期不可切除结直肠腺癌 | NRAS基因突变阴性美国
-
Eli Lilly and Company完全的